Drug Type Recombinant protein |
Synonyms Novolin N, 诺和灵N |
Target |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | CN | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Phase 3 | ES | 01 Apr 2005 | |
Diabetes Mellitus, Type 1 | Phase 3 | JP | 01 Apr 2003 | |
Diabetes Mellitus, Type 2 | Phase 3 | BE | 01 Mar 2003 | |
Diabetes Mellitus, Type 2 | Phase 3 | HR | 01 Mar 2003 | |
Diabetes Mellitus, Type 2 | Phase 3 | DK | 01 Mar 2003 | |
Diabetes Mellitus, Type 2 | Phase 3 | FR | 01 Mar 2003 | |
Diabetes Mellitus, Type 2 | Phase 3 | MK | 01 Mar 2003 | |
Diabetes Mellitus, Type 2 | Phase 3 | NO | 01 Mar 2003 | |
Diabetes Mellitus, Type 2 | Phase 3 | PL | 01 Mar 2003 | |
Diabetes Mellitus, Type 2 | Phase 3 | RU | 01 Mar 2003 |